REFERENCES
- Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992; 267: 10931–10934, [PUBMED], [INFOTRIEVE], [CSA]
- Hockel M, Schlenger K, Doctrow S, et al. Therapeutic angiogenesis. Arch Surg. 1993; 128: 423–429, [PUBMED], [INFOTRIEVE], [CSA]
- Davis M D. Proliferative diabetic retinopathy. Retina, S J Ryan. C. V. Mosby, St. Louis 1994; 1319–1360
- Glaser B M, Lemor M. Pathobiology of proliferative vitreoretinopathy. Retina, S. J. Ryan. C. V. Mosby, St. Louis 1994; 2249–2264
- Elman M J, Fine S L. Exudative age-related macular degeneration. Retina, S. J. Ryan. C. V. Mosby, St. Louis 1994; 1103–1142
- De La Paz M, nderson R E. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci. 1992; 33: 3497–3499, [PUBMED], [INFOTRIEVE], [CSA]
- Spaide R F, Ho-Spaide W C, Browne R W, Armstrong D. Characterization of peroxidized lipids in Bruch's membrane. Retina 1999; 19(2)141–147, [PUBMED], [INFOTRIEVE], [CSA]
- Armstrong D, Abdella N, Salman A, et al. Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. J Diabetes Comp. 1992; 6(2)116–122, [CROSSREF], [CSA]
- Armstrong D, Ueda T, Ueda T, et al. Lipid hydoroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-α, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis 1998; 2: 93–104, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ueda T, Ueda T, Fukuda S, et al. Lipid hydroperoxide-induced tumor necrosis factor (TNF)-α, vascular endothelial growth factor and neovascularization in the rabbit cornea: Effect of TNF inhibition. Angiogenesis 1997; 1: 174–184, [CROSSREF], [CSA]
- Tamai K, Spaide R F, Ellis E A, et al. Lipid hydroperoxide stimulates subretinal choroidal neovascularization in the rabbit. Exp Eye Res. 2002; 74(2)301–308, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Armstrong D, Hiramitsu T, Gutteridge J, Nilssen S E. Studies on experimentally induced retinal degeneration. 1. Effect of lipid peroxides on electroretinographic activity in albino rabbits. Exp Eye Res. 1982; 35: 157–171, [PUBMED], [INFOTRIEVE], [CSA]
- Armstrong D, Ueda T O, . Dose dependent mechanisms of lipid hydroperoxide induced retinal pathology. Pathophysiology of Lipid Peroxides and Related Free Radicals, K. Yagi, et al. Japan Sci Soc Press, Basel 1998; 57–76, Tokyo and S. Karger AG
- Rundhaug J E. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005; 9(2)267–285, [PUBMED], [INFOTRIEVE], [CSA]
- Kon C H, Occleston N L, Charteris D, et al. A prospective study of matrix metalloproteinases in proliferative vitreoretinapathy. Invest Ophthalmol. Vis Sci. 1998; 39: 1524–1529, [PUBMED], [INFOTRIEVE], [CSA]
- Kvanta A, Sarman S, Fagerholm P, et al. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp Eye Res. 2000; 70: 419–428, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Plantner J J, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res. 1998; 67: 637–645, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Guo L i, Hussain A A, Limb A, Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest Ophthalmol Vis Sci. 1999; 40: 2676–2682, [PUBMED], [INFOTRIEVE], [CSA]
- Murphy G, Ward R, Hembry R M, et al. Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J. 1989; 258(2)463–472, [PUBMED], [INFOTRIEVE], [CSA]
- Vu T H, Werb Z. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev. 2000; 14: 2123–2133, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Leppert D, Lindberg R L, Kappos L, Leib S L. Matrix metalloproteinases: Multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev. 2001; 36(2–3)249–257, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Benbow U, Brinckerhoff C E. The AP-1 site and MMP gene regulation: What is all the fuss about?. Matrix Biol. 1997; 15(8–9)519–526, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fei J, Viedt C, Soto U, et al. Endothelin-1 and smooth muscle cells: Induction of jun amino-terminal kinase through an oxygen radical-sensitive mechanism. Arterioscler Thromb Vasc Biol. 2000; 20: 1244–1249, [PUBMED], [INFOTRIEVE], [CSA]
- Dabrowski A, Boguslowicz C, Dabrowska M, et al. Reactive oxygen species activate mitogen-activated protein kinases in pancreatic acinar cells. Pancreas 2000; 21(4)376–384, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Virag L. Structure and function of poly (ADP-ribose) polymerase-1: Role in oxidative stress-related pathologies. Curr Vasc Pharmacol. 2005; 3(3)209–214, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Virag L, Szabo C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev. 2002; 54(3)375–429, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Armstrong D, Browne R W. Synthesis of lipid and cholesterol hydroperoxide standards. Free Radical and Antioxidant Protocols. Metheods in Molecular Biology, D. Armstrong. Humana Press, Totowa, NJ 1998; vol. 108: 139–45
- Browne R W, Armstrong D. Simultaneous determination of polyunsaturated fatty acids and corresponding monohydroperoxy and monohydroxy peroxidation products by HPLC. Oxidative Stress Biomarkers and Antioxidant Protocols, Metheods in Mololerular Biology, D Armstrong. Humana Press, Totowa, NJ 2002; vol. 186: 13–20
- Sasaki K, Hattori T, Fujisawa T, et al. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J. Biochem. 1998; 123(3)431–439, [PUBMED], [INFOTRIEVE], [CSA]
- Grant M B, Caballero S, Tarnuzzer R W, et al. Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes 1998; 47: 1311–1317, [PUBMED], [INFOTRIEVE], [CSA]
- Friedrichs B, Toborek M, Hennig B, et al. 13-HPODE and 13-HODE modulate cytokine-induced expression of endothelial cell adhesion molecules differently. Biofactors 1999; 9(1)61–72, [PUBMED], [INFOTRIEVE], [CSA]
- Nagy L, Tontonoz P, Alvarez J GA, et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 1998; 93: 229–240, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Armstrong D, Browne R W. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol. 1994; 366: 43–58, [PUBMED], [INFOTRIEVE], [CSA]
- Leonarduzzi G, Arkan M C, Başaĝa H, et al. Lipid oxidation products in cell signaling. Free Radic Biol Med. 2000; 28(9)1370–1378, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moses M A, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990; 248: 1408–1410, [PUBMED], [INFOTRIEVE], [CSA]
- Klagsbrun M, Moses M A. Molecular angiogenesis. Chem Biol. 1999; 6: R217–224, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Iruela-Arispe M L, Dvorak H F. Angiogenesis: A dynamic balance of stimulators and inhibitors. Thromb Haemost. 1997; 78(1)672–677, [PUBMED], [INFOTRIEVE], [CSA]
- Burdon R H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med. 1995; 18(4)775–794, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Guha M, Bai W, Nadler J L, Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem. 2000; 275(23)17728–17739, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lee Y W, Hennig B, Fiala M, et al. Cocaine activates redox-regulated transcription factors and induces TNF-alpha expression in human brain endothelial cells. Brain Res. 2001; 920(1–2)125–133, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rosenfeld M E. Inflammation, lipids, and free radicals: Lessons learned from the atherogenic process. Semin Reprod Endocrinol. 1998; 16(4)249–261, [PUBMED], [INFOTRIEVE], [CSA]
- Majka S, McGuire P G, Das A. Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci. 2002; 43(1)260–266, [PUBMED], [INFOTRIEVE], [CSA]
- Alikacem N, Yoshizawa T, Nelson K D, Wilson C A. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbit. Invest Ophthalmol Vis Sci. 2000; 41: 1561–1569, [PUBMED], [INFOTRIEVE], [CSA]
- Lin C W, Georgescu H I, Evans C H. The role of AP-1 in matrix metalloproteinase gene expression. Agents Actions. 1993; 39: C215–218, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gum R, Lengyel E, Juarez J, et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem. 1996; 271: 10672–10680, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Himelstein B P, Lee E J, Sato H, et al. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 1997; 14: 1995–1998, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bond M, Fabunmi R P, Baker A H, Newby A C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-κB. FEBS Lett. 1998; 435: 29–34, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Troussard A A, Costello P, Yoganathan T N, et al. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9(MMP-9). Oncogene 2000; 19: 5444–5452, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fariss R N, Apte S S, Luthert P J, et al. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol 1998; 82(11)1329–1334, [PUBMED], [INFOTRIEVE], [CSA]
- Sang Q X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 1998; 8(3)171–177, [PUBMED], [INFOTRIEVE], [CSA]
- Ikenaka Y, Yoshiji H, Kuriyama S, et al. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int J Cancer 2003; 105(3)340–346, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Huhtala P, Chow L T, Tryggvason K. Structure of the human type IV collagenase gene. J Biol Chem. 1990; 265(19)11077–11082, [PUBMED], [INFOTRIEVE], [CSA]
- Frisch S M, Morisaki J H. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol Cell Biol. 1990; 10(12)6524–6532, [PUBMED], [INFOTRIEVE], [CSA]
- Harendza S, Pollock A S, Mertens P R, Lovett D H. Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem. 1995; 270(32)18786–18796, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tomasek J J, Halliday N L, Updike D L, et al. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem. 1997; 272: 7482–7487, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Strongin A Y, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. J Biol Chem. 1995; 270: 5331–5338, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Laderoute K R, Calaoagan J M, Knapp A M, et al. C-jun cooperate with SV40 T-antigen to sustain MMP-2 expression in immortalized cells. Biochem Biophys Res Commun. 2001; 284(5)1134–1139, [PUBMED], [INFOTRIEVE], [CSA]
- Plantner J J, Smine A, Quinn T A. Matrix metalloproteinase and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous. Curr Eye Res. 1998b; 17: 132–40, [PUBMED], [INFOTRIEVE], [CSA]
- De La Paz M A, Itoh Y, Toth C A, Nagase H. Matrix metalloproteinases and their inhibitors in human vitreous. Invest Ophthalmol Vis Sci. 1998; 39: 1256–1260, [PUBMED], [INFOTRIEVE], [CSA]
- Behzadian M A, Wang X, Windsor L J, et al. TGF-b increases retinal endothelial cell permeability by increasing MMP-9: Possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci. 2001; 42: 853–859, [PUBMED], [INFOTRIEVE], [CSA]
- Zhang X, Sakamoto T, Hata Y, et al. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Exp Eye Res. 2002; 74(5)577–584, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Padgett L C, Lui G, Werb Z, LaVail M M. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in retinal pigment epithelium and interphotoreceptor matrix: Vectorial secretion and regulation. Exp Eye Res. 1997; 64: 927–938, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lengyel E, Schmalfeldt B, Konik E, et al. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol. 2001; 82: 291–298, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zucker S, Lysik R M, Zarrabi M H, Moll U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 1993; 53: 140–146, [PUBMED], [INFOTRIEVE], [CSA]
- Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999; 13: 35–48, [PUBMED], [INFOTRIEVE], [CSA]
- Uemura S, Matsushita H, Li W, , Tsao P S, et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity role of oxidative stress. Circ Res. 2001; 88: 1291–1298, [PUBMED], [INFOTRIEVE], [CSA]
- Sarman S, van der Ploeg I, Seregard S, Kvanta A. Retinal vascular development and pathologic retinal angiogenesis are not impaired in matrix metalloproteinase-2 deficient mice. Curr Eye Res. 2005; 30(4)259–267, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kosano H, Okano T, Katsura Y, et al. ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy. Life Sci. 1999; 64: 2307–2315, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lambert V, Munaut C, Jost M, et al. Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol. 2002; 161(4)1247–1253, [PUBMED], [INFOTRIEVE], [CSA]